Nieca Goldberg, MD, a board-certified cardiologist, educator, author, and advocate for women’s health, who is passionate about changing the narrative around heart health, from prevention to treatment. Dr. Nieca is a national spokesperson for the American Heart Association and started the “Go Red for Women” campaign. She also currently serves as Board Member of HealthyWomen, was previously medical director of NYU Women’s Heart Program, and hosts the podcast Beyond the Heart™. Dr. Nieca is the author of award winning and highly acclaimed books and has made numerous appearances on programs such as The Today Show, The View, Good Morning America, CNN, and CBS Evening News to raise awareness of heart health best practices.

• Evaluate how traditional and non-traditional cardiovascular (CV) risk factors impact women's CV risk across the life span
• Unlock a current understanding of the presentations and mechanisms of ischemia in women
• Examine how we can tailor cardiovascular practice to incorporate sex-specific considerations to enhance women’s CV health and well-being

Josh Hamilton, DNP, APRN-BC, CTMH, CNE, CLNC, FAANP, practices telepsychiatry on a national scale. He was associate medical director for a very large managed care behavioral health network, is a NEI Master Psychopharmacologist, and a fellow of the American Association of Nurse Practitioners. The Point of Care Network proclaimed Josh to be America’s Top Psychiatric NP in 2021.

• Explore novel pathways involved in the etiology of depression, including glutamatergic and GABAergic modulation
• Discover when newer pharmacologic agents, including neuroactive steroids and glutamatergic antidepressants are appropriate
• Evaluate the efficacy and unique safety profiles associated with novel antidepressants

Eric Christianson, PharmD, BCGP, BCPS, board certified in geriatrics and pharmacotherapy, an Amazon best-selling author, podcaster, consultant, and national speaker. He has authored numerous books on geriatric pharmacology and has been featured in the Wall Street Journal, American Journal of Nursing, National Association Directors of Nursing, Pharmacy Times, and Pharmacy Today.

• Individualize medication regimens by adjusting dosages based on lab results, thus promoting personalized medicine
• Determine important drug interactions that may affect laboratory parameters
• Make informed decisions that enhance the quality of life for elderly patients

Ahunna Freeman, PharmD, BCGP, the clinical pharmacist for a seven-provider medical practice. Dr. Freeman has successfully implemented a remote patient monitoring program, a chronic care management program, and a pharmacist-led weight management program. She is passionate about pharmacist-provider collaborations that provide real patient care solutions.

• AOMs: Initiating dose and formulations, therapeutic strength, monitoring plans, treatment based on comorbidities, use with other medications/potential interactions, cost considerations
• Study trial results for the newest class of AOMs for clinical significance
• Highlights from current research on AOMs

Deidre Arms MSN, APRN, CNP, is a dedicated Functional Medicine Nurse Practitioner and co-founder of Desire Wellness Group. Deidre sees patients to explore causes of imbalanced female hormones, menopausal symptoms, poor sleep, chronic fatigue, obesity, autoimmune disorders through personalized tools, individualized testing, and lifestyle modification.

• Explore the various forms of HRT available, with respect to the advantages and drawbacks to each
• Incorporate the current guidelines and recommendations to aid in clinical decision-making
• Consider alternative and complementary therapies for patients who cannot or choose not to use HRT

Kelly Sklanka, PharmD an Assistant Professor in the Department of Pharmacy Practice at the Wilkes University Nesbitt School of Pharmacy and operates a clinical telepharmacy practice site. Previously, Kelly worked as an ambulatory care clinical pharmacist, often helping providers select appropriate medication treatments for various conditions, including orthopedic injuries and perioperative recommendations.

• Antirheumatic medications & their role to manage autoimmune and inflammatory components of orthopedic diseases
• Strategic use of antidepressants and antiepileptics for orthopedic pain management
• Perioperative preparations with considerations for specific medications length of pause

Steven Rubin, MD, in Adult and Geriatric Neurocognitive and Behavioral health care. He is certified by The American Board of Psychiatry and Neurology and has been in private practice for 30 years. Dr. Rubin has been a Clinical Associate Professor with the University of Reno School of Medicine and a member of the Nevada Medicaid Drug Utilization Review Board.

• Combine evidence-based practice with more traditional prescriptive methods to help patients achieve quality longevity
• Evaluate risks and benefits of prescription and non-prescription pharmaceutical agents
• Incorporate updated geriatric psychopharmacology guidelines

Mary Lynn McPherson, Pharm.D., PhD, BCPS, FAAHPM, is Professor and Executive Director, of Graduate Studies in Palliative Care at the University of Maryland, Baltimore. She has maintained a practice in hospice (local and national) her entire career, is particularly interested in opioid conversion calculations, and developed the first palliative care pharmacy specialty residency in the U.S.

• Determine the steps in the drug therapy selection for pain in serious illness
• Differentiate between subjective and objective monitoring parameters for therapeutic effectiveness and potential toxicity
• Evaluate best practice therapeutic approaches to non-pain symptoms in serious illness (e.g., nausea, anxiety, depression, dyspnea, constipation)

Kelly Sklanka, PharmD, an Assistant Professor in the Department of Pharmacy Practice at the Wilkes University Nesbitt School of Pharmacy and operates a clinical telepharmacy practice site. Previously, Kelly worked as an ambulatory care clinical pharmacist, often helping providers select appropriate medication treatments for various conditions, including migraines.

• Available medications for abortive use and migraine prophylaxis
• Specific pearls and guidelines to develop individualized patient treatment plans
• Through case studies and evidence-based reviews, help women achieve more migraine free days